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Background:  Although observational studies have shown comparable beneficial effect of cardiac resynchronization therapy (CRT) in de 
novo implantations as compared to those upgraded from right ventricular (RV) pacing, predictors of a favorable response to CRT in the 
latter group have not been described. The aim of this study was to identify factors associated with CRT response, in terms of left ventricular 
(LV) reverse remodeling, among patients previously implanted with a pacemaker or an implantable cardioverter defibrillator.
methods:  A total of 312 patients upgraded to CRT were included. Prior to upgrade and after 6 months, clinical and echocardiographic 
evaluation was performed. Response to CRT was defined as ≥15% reduction in LV end-systolic volume at follow-up.
results:  At 6-months follow-up, 166 patients (55%) were classified as CRT responders. Baseline characteristics of the study population, 
compared between CRT responders and non-responders, are shown in the Table. By multivariate logistic regression analysis, eGFR 
(OR 1.01; p=0.03), chronic RV pacing (OR 1.8; p=0.03), QRS duration (OR 1.01; p=0.03) and LV dyssynchrony (OR 1.74; p=0.03) were 
independently associated with CRT response.
conclusion:  In patients upgraded to CRT, chronic RV pacing, wider QRS, LV dyssynchrony and better renal function at baseline are 
associated with significant LV reverse remodeling after implantation. These characteristics may therefore be considered to optimize patient 
selection for upgrade to CRT.
Baseline characteristics CRT Responders (n=166) CRT Non-responders (n=146) p-value
Age, year 66.5 ± 10.8 65.8 ± 10.0 0.580
Gender, male n (%) 133 (80.1) 122 (83.6) 0.523
Etiology, ischemic n (%) 86 (58.9) 78 (53.0) 0.352
NYHA ≥ III, n (%) 111 (68.1) 110 (76.9) 0.111
6MWT, m 343 ± 130 318 ± 123 0.113
Minnesota Living with Heart Failure Questionnaire 33 ± 17 36 ± 18 0.119
Diabetes, n (%) 22 (13.3) 21 (14.4) 0.901
eGFR, mL/min/kg 65 ± 25 60 ± 25 0.056
Hemoglobin, mmol/L 8.4 ± 1.0 8.3 ± 1.0 0.373
Device before upgrade, PM n (%) 93 (56.0) 60 (41.1) 0.012
Chronic RV pacing, ≥90% n (%) 96 (57.8) 55 (37.7) 0.001
QRS morphology, LBBB* n (%) 52 (31.3) 56 (38.4) 0.237
QRS duration, ms 188 ± 28 176 ± 29 0.001
History of AF, n (%) 42 (25.3) 34 (23.3) 0.779
Echocardiographic parameters
LVEDV, mL 210 ± 77 206 ± 81 0.601
LVESV, mL 156 ± 68 152 ± 70 0.604
LVEF, % 27 ± 9 28 ± 10 0.679
LV dyssynchrony, SL delay ≥60ms n (%) 102 (63.8) 71 (52.6) 0.069
6MWT, 6 minute walking test; AF, atrial fibrillation; eGFR, estimated glomerular filtration rate; LBBB, left bundle branch block; LVEDV, LV 
end diastolic volume; LVESV, LV end systolic volume; PM, pacemaker; SL delay, TDI derived septal to lateral delay.
*Amongst those with intrinsic rhythm on pre-upgrade ECG.
